Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 2013. The document serves as a notification of transactions involving a person discharging managerial responsibility, specifically regarding changes in share interests.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific share transaction and does not contain financial statements or performance metrics.
Material Changes
The filing details a transaction on October 7, 2013, where Mr. S M Bicknell purchased 24 Ordinary Shares at a price of 1549.50 pence per share. This acquisition resulted from the re-investment of dividends on shares held within an Individual Savings Account (ISA).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document strictly reports a regulatory disclosure of a director's share transaction.
Key Facts for Investors
- Transaction Date: October 7, 2013.
- Individual: Mr. S M Bicknell (Person Discharging Managerial Responsibility).
- Share Count: 24 Ordinary Shares purchased.
- Price: 1549.50 pence per share.
- Source of Funds: Re-investment of dividends within an ISA.
- Notification Date: The company was advised of the transaction on October 8, 2013.